ELTROMBOPAG AS FIRST-LINE TREATMENT IN SEVERE APLASTIC ANEMIA: A COST-EFFECTIVENESS ANALYSIS FROM THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM PERSPECTIVE by MA Salvino, C Bonfim, RT Calado, H Kim, JF Bertinato, P Scheinberg

Get full text

SAFETY AND EFFICACY FINDINGS OF A PHASE 1B/2 STUDY OF NANATINOSTAT PLUS VALGANCICLOVIR FOR TREATMENT OF RELAPSED/REFRACTORY EPSTEIN-BARR VIRUS-POSITIVE DIFFUSE LARGE B-CELL LYMPHOM... by M Capra, P Scheinberg, J Pereira, B Haverkos, S Spruill, D Strickland, P Porcu

Get full text

A PHASE 1B/2 STUDY EVALUATING THE SAFETY AND EFFICACY OF NANATINOSTAT PLUS VALGANCICLOVIR FOR TREATMENT OF RELAPSED/REFRACTORY EPSTEIN-BARR VIRUS-POSITIVE NODAL PERIPHERAL T-CELL L... by J Pereira, P Scheinberg, M Capra, P Porcu, S Spruill, D Strickland, B Haverkos

Get full text

Erratum on ‘‘Eltrombopag as first-line treatment in severe aplastic anemia: a cost-effectiveness analysis from the Brazilian public healthcare system perspective” by M.A. Salvino, C. Bonfim, R.T. Calado, H. Kim, J.F. Bertinato, P. Scheinberg

Get full text

HCT-CI AS A PREDICTOR OF ICU ADMISSION: BRAZILIAN SINGLE-CENTER COHORT STUDY by PPF Machado, AD Americo, EL Rosa, GGM Lima, JUA Filho, FPS Santos, BM Gusmão, FR Kerbauy, P Scheinberg

Get full text

IN VIVO EFFECTS OF ELTROMBOPAG ON THE EXPANSION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS IN APLASTIC ANAEMIA by B.Q. Oliveira, B.A.A.S. Lemos, L.F.B. Catto, M.F. Tellechea, P. Scheinberg, P.S. Scheucher, R.T. Calado

Get full text

THROMBOEMBOLIC AND BLEEDING EVENTS IN ICU PATIENTS WITH COVID-19: RESULTS FROM A BRAZILIAN TERTIARY HOSPITAL by A.A.G.S. Brandão, D.L.C. Farias, S.O. Rojas, A.A.M. Ordinola, V.M. Queiroz, P. Scheinberg, V. Veiga

Get full text

CLINICAL CHARACTERISTICS AND OUTCOMES OF BRAZILIAN PATIENTS WITH CASTLEMAN DISEASE: A BRAZILIAN MULTICENTRIC COHORT OF A RARE HEMATOLOGICAL DISORDER by A.A.G.S. Brandão, R.C.B. Melo, M. Bellesso, M.A.F. Aranha, H.S. Fernandes, D.L.C. Farias, P. Scheinberg, J. Pereira, E.M. Rego, V. Rocha

Get full text

OUTPATIENT SUBCUTANEOUS ALEMTUZUMAB IS FEASIBLE AND SAFE FOR APLASTIC ANEMIA AND ASSOCIATED WITH HIGH RESPONSE RATES by AR Fonseca, CC Justino, VC Molla, PE Yamakawa, IB Rabelo, A Hill, L Arnold, R Kelly, M Griffin, T Munir, E Velloso, T Dalessandro, AM Risitano, P Scheinberg, A Kulasekararaj, C Arrais-Rodrigues

Get full text